Enhancement of intranasal vaccination-improved immune protection and cost-effictiveness by combining optimised mucosal adjuvant and nasal delivery system (NASAL VACCINATION)

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-2. - Key action Control of Infectious Diseases

Funding Scheme

CRS - Cooperative research contracts

Coordinator

EUROCINE AB

Address

Karolinska Institute Science Park, Foqdevreten 2
171 77 Stockholm
Sweden

Participants (6)

DIABACT AB

Sweden

Address

Kungsgatan, 109
751 05 Uppsala

FEM DESIGN AS

Norway

Address

Sagveien, 21
0459 Oslo

FOUNDATION FOR TECHNICAL AND INDUSTRIAL RESEARCH AT THE NORWEGIAN INSTITUTE OF TECHNOLOGY

Norway

Address

1 D,strindveien 4
7465 Trondheim

OPTINOSE AS

Norway

Address

Lokka Skogen 18C
0773 Oslo

SIUMSURGERY AS

Norway

Address

Sognsveien, 75 B
0865 Oslo

SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL

Sweden

Address

2,Nobels Vaag 18
171 82 Solna